- Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - -
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Pharvaris To Present Clinical And Nonclinical Data At Upcoming Congresses menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
A single infusion of a gene-editing medicine may control inherited high LDL cholesterol medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Company to hold investor event in conjunction with data presentation on November 12, 2023 BOSTON, Sept. 26, 2023 Verve Therapeutics, a clinical-stage biotechnology company pioneering a new.